XCyton Diagnostics
XCyton is a revolutionary Molecular Biology Company founded in 1993, dedicated to developing innovative diagnostic products and services. Its mission is to save lives and prevent disabilities through cutting-edge science and technology, aiming to become a global leader in diagnostic product development and to put India on the world map of medical diagnostics. The company emphasizes integrity, excellence, responsibility, and team spirit, and has received several awards including the Bio-Singapore Award and the Best Bio-Product Award. XCyton has a strong in-house research team and collaborates with reputed institutes, focusing on critical care infections and syndrome-based diagnostics, revolutionizing critical care management with its Syndrome Evaluation System.
Industries
Nr. of Employees
small (1-50)
XCyton Diagnostics
No.449, 10th Cross, 4th Phase, Peenya Industrial Area, Bangalore 560 058, India
Products
Multiplex molecular diagnostic platform (syndrome-based)
Patented platform combining multiplex nucleic-acid amplification and syndrome-specific hybridization for simultaneous identification of multiple pathogen classes from a single sample; positioned for critical-care infectious disease diagnosis.
Immunodiagnostic ELISA kits for infectious diseases
Series of enzyme-linked immunosorbent assay kits developed for serological detection of infectious agents (examples noted historically include assays for HIV, Hepatitis C, Japanese encephalitis and neurocysticercosis).
Multiplex molecular diagnostic platform (syndrome-based)
Patented platform combining multiplex nucleic-acid amplification and syndrome-specific hybridization for simultaneous identification of multiple pathogen classes from a single sample; positioned for critical-care infectious disease diagnosis.
Immunodiagnostic ELISA kits for infectious diseases
Series of enzyme-linked immunosorbent assay kits developed for serological detection of infectious agents (examples noted historically include assays for HIV, Hepatitis C, Japanese encephalitis and neurocysticercosis).
Services
Laboratory testing service using multiplex amplification and hybridization to detect multiple pathogens in clinical syndromes including CNS infections, sepsis, pneumonia, ophthalmic infections and febrile illnesses; reported turnaround ~7 hours.
Panel testing services for defined indications (meningitis/encephalitis, sepsis, pneumonia, ophthalmic infections, transplant and neutropenia-associated infections, dengue-chikungunya, HPV genotyping, antibiotic-resistance markers).
Laboratory testing service using multiplex amplification and hybridization to detect multiple pathogens in clinical syndromes including CNS infections, sepsis, pneumonia, ophthalmic infections and febrile illnesses; reported turnaround ~7 hours.
Panel testing services for defined indications (meningitis/encephalitis, sepsis, pneumonia, ophthalmic infections, transplant and neutropenia-associated infections, dengue-chikungunya, HPV genotyping, antibiotic-resistance markers).
Expertise Areas
- Molecular diagnostics
- Clinical microbiology and infectious disease testing
- Multiplex assay development
- Immunodiagnostic (ELISA) development
Key Technologies
- Multiplex PCR
- Hybridization-based target identification
- Nucleic-acid extraction
- RNA and DNA pathogen detection
News & Updates
Coverage by Deccan Chronicle on 18.3.12 about XCyton's diagnostic technology.
Coverage by The Hindu Business Line on 18.3.12 about funding received by XCyton.
Coverage by Times of India on 18.3.12 about rapid diagnostic results.
Coverage by Economic Times on 19.3.12 about diagnostic technology.
Bio-Singapore Award
Awarded for the most important technology developed in Asia in 2009.
Best Bio-Product Award for Syndrome Evaluation System
Received from Biospectrum in 2008.
Coverage by Deccan Chronicle on 18.3.12 about XCyton's diagnostic technology.
Coverage by The Hindu Business Line on 18.3.12 about funding received by XCyton.
Coverage by Times of India on 18.3.12 about rapid diagnostic results.
Coverage by Economic Times on 19.3.12 about diagnostic technology.
Bio-Singapore Award
Awarded for the most important technology developed in Asia in 2009.
Best Bio-Product Award for Syndrome Evaluation System
Received from Biospectrum in 2008.